Wegovy™ has recently been approved by the United States medicines regulator, the FDA, to aid weight loss. Like the Saxenda weight loss pen it is an injection that can be used to suppress your appetite and therefore aid in your weight loss journey. The only difference between Saxenda and Wegovy™ is that Saxenda is once-daily dosing and Wegovy™ is a once-weekly dosing.
Wegovy™ is a prescription-only weight loss injection. The active ingredient in Wegovy™ is semaglutide, this is the same drug that is in Ozempic. The difference between Ozempic and Wegovy™ is that Ozempic is only licensed for use in diabetics and it comes in a different strength compared to Wegovy™, which comes in a single strength of 2.4mg.
The Wegovy™ (semaglutide) injection 2.4 mg is an injectable prescription medicine used for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems (e.g high blood pressure, type-2-diabetes, high cholesterol) to help them lose weight and keep the weight off.
Wegovy™ (semaglutide 2.4mg) is a self injectable weight loss treatment. It containts the active ingredient semaglutide which is very similar to a naturally occuring hormon in the human body called Glucagon-Like Peptide 1 (GLP-1), which belongs to a family of hormones in the body called incretins.
After a meal GLP-1 is naturally released from your intestines to help regulate your blood sugar levels and reduce the amount of glucagon in your body. Glucagon is a naturally occurring hormone that works by inhibiting the action of insulin. As a result, it makes you feel less hungry, slows down the emptying of your stomach and makes you feel ‘fuller’ for longer.
In summary, Wegovy™ ‘tricks’ your body into producing more GLP-1 and therefore sends signals to your brain that you are full and do not need to eat.
The most commonly reported side effects in clinical trials were:
Other side effects included abdominal pain, headache, fatigue, and dizziness.
In animal studies, semaglutide was associated with an increased risk of thyroid tumours. This link has not been determined in humans, but Wegovy should not be taken by people with a personal or family history of thyroid tumours or a condition called MEN-2.
Wegovy has been associated with other serious side effects like acute pancreatitis, gallbladder disease, heart rate increase and kidney injury.
| Dosage | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
|---|
© 2024 Created. glp1weightlosspharmacysolution
Reviews
There are no reviews yet.